Remove Bacteria Remove Gene Expression Remove Life Science Remove Medicine
article thumbnail

Artificial intelligence could be new blueprint for precision drug discovery

The Pharma Data

online issue of Nature Communications, researchers at University of California San Diego School of Medicine describe a new approach that uses machine learning to hunt for disease targets and then predicts whether a drug is likely to receive FDA approval. “Academic labs and pharmaceutical and? the success rates in drug discovery?are

Drugs 52
article thumbnail

Otto Bayer Award goes to Prof. Ruth Ley PhD

The Pharma Data

Her cryo-electron microscopy studies include analysis of nuclear peripheries and the machinery of gene expression in bacteria. In the Medicine category Dr. Nicolai Franzmeier (LMU Munich) was honored for developing new imaging techniques to investigate Alzheimer’s disease.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Women in Science Who Have Paved the Way Forward in Genetics

XTalks

Geneticist Martha Chase was a key partner of the foundational Hershey-Chase experiment that helped confirm DNA to be the carrier of genetic information; however, it was only Hershey of the pair that went on to win the Nobel Prize in Physiology or Medicine in 1969 for the discovery. Chase’s exclusion from the prize remains a mystery.

Genetics 119
article thumbnail

CRISPR breakthroughs: New solutions for common diseases

Drug Discovery World

Rolf Turk , Senior Manager, Genomics Medicine at Integrated DNA Technologies, examines how CRISPR is being used to enhance cancer therapies. These efforts, along with many others, are opening doors for new possibilities in translational medicine. Herpesviridae, Polyomaviridae, and Papillomaviridae), bacteria (e.g.,

DNA 98
article thumbnail

2020 Year in Review: COVID-19, CRISPR and Immunotherapies Define the Year for the Life Sciences

XTalks

The pandemic propelled the life science and healthcare sectors onto center stage, and they rose to the occasion against the most unprecedented health challenge in recent times. While COVID-19 has undoubtedly been the biggest story in the life science industry in 2020, it was a busy and positive year in many other areas.